by lsmith | Feb 18, 2015 | Human Microbiome, Obesity
Fecal microbiota transplantation (FMT) involves the transfer of fecal material from a healthy donor to the digestive tract of an ill recipient (most commonly, someone with refractory, or difficult to manage, C. difficile diarrhea). Transplanting the gut microbiota...
by lsmith | Jan 7, 2015 | Heartburn, Human Microbiome, PPIs
Proton pump inhibitors (PPIs) are one of the most commonly prescribed medications in the United States, earning billions of dollars for pharmaceutical companies. PPIs markedly decrease the production of stomach acid as a treatment for conditions in the upper digestive...
by Brenda Watson | Dec 22, 2014 | C. difficile, Human Microbiome
“Give a sh!t. Save a life.” Literally. If you have yet to make end of the year charitable contributions, I have just the organization for you. OpenBiome’s slogan, although crude, couldn’t be more true. In an effort to raise funds the nonprofit organization is...
by lsmith | Mar 6, 2013 | General
The story unfolding about Clostridium difficile (C. diff for short) infection is one I pay close attention to. There is no effective treatment for recurrent C. diff infection, which puts this population at higher risk of complications, including death. In fact, it was...
by lsmith | Oct 31, 2012 | General
The bacterium Clostridium difficile (also known as C. diff) is a major pathogenic contributor to the development of antibiotic-associated diarrhea, or diarrhea that results from taking an antibiotic. According to the Centers for Disease Control (CDC), C. difficile...
